HomeCompareSHWGF vs KMB

SHWGF vs KMB: Dividend Comparison 2026

SHWGF yields 3.85% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHWGF wins by $70.2K in total portfolio value· pulled ahead in Year 3
10 years
SHWGF
SHWGF
● Live price
3.85%
Share price
$0.52
Annual div
$0.02
5Y div CAGR
38.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$116.0K
Annual income
$38,332.89
Full SHWGF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — SHWGF vs KMB

📍 SHWGF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHWGFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHWGF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHWGF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHWGF
Annual income on $10K today (after 15% tax)
$326.92/yr
After 10yr DRIP, annual income (after tax)
$32,582.96/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, SHWGF beats the other by $28,153.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHWGF + KMB for your $10,000?

SHWGF: 50%KMB: 50%
100% KMB50/50100% SHWGF
Portfolio after 10yr
$81.0K
Annual income
$21,772.11/yr
Blended yield
26.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

SHWGF
No analyst data
Altman Z
2.6
Piotroski
6/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHWGF buys
0
KMB buys
0
No recent congressional trades found for SHWGF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHWGFKMB
Forward yield3.85%5.25%
Annual dividend / share$0.02$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.1%17%
Portfolio after 10y$116.0K$45.9K
Annual income after 10y$38,332.89$5,211.33
Total dividends collected$87.0K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: SHWGF vs KMB ($10,000, DRIP)

YearSHWGF PortfolioSHWGF Income/yrKMB PortfolioKMB Income/yrGap
1$11,231$531.15$11,314$613.68$83.00KMB
2$12,787$769.94$12,865$759.19$78.00KMB
3← crossover$14,814$1,131.40$14,709$943.96+$105.00SHWGF
4$17,542$1,691.67$16,919$1,180.17+$623.00SHWGF
5$21,356$2,585.53$19,588$1,484.33+$1.8KSHWGF
6$26,913$4,062.45$22,838$1,879.06+$4.1KSHWGF
7$35,405$6,607.64$26,832$2,395.60+$8.6KSHWGF
8$49,102$11,218.96$31,788$3,077.63+$17.3KSHWGF
9$72,621$20,081.68$38,000$3,986.82+$34.6KSHWGF
10$116,037$38,332.89$45,872$5,211.33+$70.2KSHWGF

SHWGF vs KMB: Complete Analysis 2026

SHWGFStock

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

Full SHWGF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this SHWGF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHWGF vs SCHDSHWGF vs JEPISHWGF vs OSHWGF vs KOSHWGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.